Product nameHRP Conjugation Kit - Lightning-Link®
This product is manufactured by Expedeon, an Abcam company. Expedeon product code 701-0003 was previously called Lightning-Link® HRP Labeling Kit 5 x up to 4 mg Ab and is the same as the 5 x 1 mg size of this product. Expedeon product code 701-0000 was previously called Lightning-Link® HRP Labeling Kit 3 x up to 400 µg Ab and is the same as the 3 x 100 µg size of this product. Expedeon product code 701-0030 was previously called Lightning-Link® HRP Labeling Kit 3 x up to 40 µg Ab and is the same as the 3 x 10 µg size of this product. Expedeon product code 701-0010 was previously called Lightning-Link® HRP Labeling Kit 1 x up to 400 µg Ab and is the same as the 100 µg size of this product. Expedeon product code 701-0002 was previously called Lightning-Link® HRP Labeling Kit 1 x up to 4 mg Ab and is the same as the 1 mg size of this product. Expedeon product code 701-0004 was previously called Lightning-Link® HRP Labeling Kit 1 x up to 20 mg Ab and is the same as the 5 mg size of this product.
HRP Conjugation Kit / HRP Labeling Kit ab102890 uses a simple and quick process for HRP labeling / conjugation of antibodies. It can also be used to conjugate other proteins or peptides. Learn about our antibody labeling kits and their advantages.
To conjugate an antibody to HRP using this kit:
- add modifier to antibody and incubate for 3 hrs
- add quencher and incubate for 30 mins
The HRP conjugated antibody can be used immediately in WB, ELISA, IHC etc. No further purification is required and 100% of the antibody is recovered for use.
Learn about buffer compatibility below; for incompatible buffers and low antibody concentrations, use our rapid antibody purification and concentration kits. Use the FAQ to learn more about the technology, or about conjugating other proteins and peptides to HRP.
Amount and volume of antibody for conjugation to HRP
Kit size Recommended
amount of antibody1
amount of antibody
30 µg 3 x 10 µg 3 x 40 µg 3 x 10 µL 100 µg 100 µg 400 µg 100 µL 300 µg 3 x 100 µg 3 x 400 µg 3 x 100 µL 1 mg 1 mg 4 mg 1 mL 5 mg 5 x 1 mg 5 x 4 mg 5 x 1 mL
1 Recommended amount of antibody will give an HRP:antibody molar ratio of 4:1. Antibodies often also perform well at the maximum amount of antibody which is 1:1 molar ratio.
2 Ideal antibody concentration is 1mg/ml. 0.5 - 1 mg/ml can be used if the maximum antibody volume is not exceeded. Antibodies > 5mg/ml or < 0.5 mg/ml should be diluted /concentrated.
Buffer Requirements for Conjugation
Buffer should be pH 6.5-8.5.
Compatible buffer constituents
If a concentration is shown, then the constituent should be no more than the concentration shown. If several constituents are close to the limit of acceptable concentration, then this can inhibit conjugation.
50mM / 0.6% Tris1 0.1% BSA 50% glycerol 0.1% sodium azide2 PBS Potassium phosphate Sodium chloride HEPES Sucrose Sodium citrate EDTA Trehalose
1 Tris buffered saline is almost always ≤ 50 mM / 0.6%
2 Sodium azide irreversibly inhibits HRP; antibodies with azide should be purified before using the HRP conjugation kit.
Incompatible buffer constituents
Thiomerosal Proclin Glycine Arginine Glutathione DTT
Only purified antibodies are suitable for use, ie. where other proteins, peptides, or amino acids are not present: antibodies in ascites fluid, serum or hybridoma culture media are incompatible.
Tested applicationsSuitable for: Conjugationmore details
Storage instructionsStore at -20°C. Please refer to protocols.
Components 100 µg 1 mg 3 x 10 µg 5 x 1 mg 3 x 100 µg 30 µg 300 µg 5 mg HRP mix 1 x 100µg 1 x 1mg 3 x 10µg 5 x 1mg 3 x 100µg 3 x 10µg 3 x 100µg 5 x 1mg Modifier reagent 1 vial 1 vial 1 vial 1 vial 1 vial 1 vial 1 vial 1 vial Quencher reagent 1 vial 1 vial 1 vial 1 vial 1 vial 1 vial 1 vial 1 vial
- Horseradish peroxidase
Our Abpromise guarantee covers the use of ab102890 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|Conjugation||Use at an assay dependent dilution.|
Gram M et al. used ab102890 to assess levels of cell free fetal haemoglobin (HbF) and haptoglobin (Hp) by ELISA.
Samples were from normal pregnancies (Control) and women diagnosed with PE. The cell-free HbF plasma concentration of each patient sample (Control and PE) was plotted against the Hp plasma concentration.
Rasmussen DG et al. used ab102890 to determine levels of C3C by competitive ELISA.
(A) Standard curve and inhibition of the competitive ELISA signal using healthy human serum, (B) human heparin plasma and (C) human EDTA plasma. The native material was run from undiluted and up to 8-fold diluted as indicated. (D) Neo-epitope specificity of the C3C ELISA was shown by comparing reactivity towards an elongated peptide, i.e. a peptide with an additional amino acid at the N-terminal generated by cleavage, a non-sense peptide, i.e. a peptide with a different sequence, and the standard peptide. The standard peptide (i.e. standard curve), elongated peptide, and non-sense peptide were diluted 2-fold from 100 ng/mL. The data is presented as percent (%) of background absorbance, which is the absorbance with only assay buffer present, as a function of peptide concentration.
Laura RP et al. used ab102890 to determine concentrations of MPO by ELISA.
The relative amounts of secreted versus cellular myeloperoxidase (MPO) were calculated for each cell line.
Kristensen JH et al. used ab102890 for the quantification of neutrophil elastase (NE)-degraded elastin (EL).
EL-NE fragment levels in serum from patients with IPF (n = 10) compared with controls (n = 9).
** p < 0.01. (B): EL-NE fragment levels in serum from patients diagnosed with lung cancer (n = 40 in total), SCC (n = 16), adenocarcinoma (n = 16) and SCLC (n = 8) compared with controls (n = 12). **** p < 0.0001. Groups were compared by T-test with Welch correction. Data are shown as the geometric mean (95% CI).
Abbreviations: IPF, idiopathic pulmonary fibrosis; SCC, squamous cell carcinoma; SCLC, small cell lung carcinoma.
HRP conjugation kit ab102890 is used by Abcam extensively in ELISA development. It is used for development / manufacturing of Abcam's SimpleStep ELISA® kits, including the Frataxin ELISA kit ab176112 used to produce the image above.
Transformed B lymphocyte cells from Friedreich's Ataxia (FA) samples were compared to heterozygous carrier B lymphocyte cells (Carrier) and control B lymphocyte cells (Control). B lymphocyte cell extracts were analyzed across a 7-point titration (0.1-100 µg/mL) and frataxin levels were interpolated from the standard curve. Average interpolated values of Frataxin are plotted.
This product has been referenced in:
- Perry H et al. Angiogenic Marker Prognostic Models in Pregnant Women With Hypertension. Hypertension N/A:HYPERTENSIONAHA11913997 (2020). Read more (PubMed: 31983309) »
- Bin Y et al. Development of an immunochromatographic strip test for rapid detection of citrus yellow vein clearing virus. Arch Virol 163:349-357 (2018). Read more (PubMed: 29075887) »